Schwake Christopher J, Eapen Mary, Lee Stephanie J, Freytes César O, Giralt Sergio A, Navarro Willis H, Rizzo J Douglas, van Besien Koen, Loberiza Fausto R
Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Biol Blood Marrow Transplant. 2005 Dec;11(12):988-98. doi: 10.1016/j.bbmt.2005.07.013.
Racial or ethnic minorities with leukemia who receive HLA-identical sibling hematopoietic stem cell transplants (HSCTs) are reported to have worse survival when compared with whites. Characteristics of US HSCT centers according to the proportion of ethnic minorities who undergo transplantation were compared to explore systematic differences among centers; the association with 100-day mortality was evaluated to determine whether center factors may explain the observed discrepant survival among ethnic minorities. One hundred sixteen US transplantation centers that performed HLA-identical sibling transplantations for leukemia were analyzed. We compared physician and health care provider staffing, transplantation unit procedure and resources, and medical center organization according to the volume procedure ratio of ethnic minorities who underwent transplantation and also according to the ratio of Hispanics who underwent transplantation. Centers that performed transplantation in a higher proportion of ethnic minorities were more likely to perform fewer transplantations per year, to have fewer devoted transplant beds, to be in an urban setting, to have a lower physician to patient volume ratio, and to follow up survivors 1 year after transplantation. Centers that performed transplantation in a higher proportion of Hispanics were more likely to perform fewer transplantations per year and to have fewer devoted transplantation beds, were less likely to perform outpatient transplantations, were more likely to be in an urban setting, and were less likely to have posttransplantation immunization protocols. Observed differences in center factors were not associated with 100-day mortality after adjustment for disease severity. Our results suggest that the inferior survival reported in ethnic minorities after HSCT may not be readily explained by center effects.
据报道,与白人相比,接受人类白细胞抗原(HLA)匹配的同胞造血干细胞移植(HSCT)的白血病种族或族裔少数群体的生存率较低。根据进行移植的少数族裔比例,对美国HSCT中心的特征进行比较,以探索各中心之间的系统性差异;评估与100天死亡率的关联,以确定中心因素是否可以解释少数族裔中观察到的生存差异。对116家为白血病患者进行HLA匹配同胞移植的美国移植中心进行了分析。我们根据接受移植的少数族裔的手术量比例以及接受移植的西班牙裔的比例,比较了医生和医疗保健人员配备、移植科室的程序和资源以及医疗中心的组织情况。进行少数族裔移植比例较高的中心,每年进行的移植手术数量更有可能较少,专门的移植床位更少,位于城市地区,医生与患者的比例更低,并且在移植后1年对幸存者进行随访。进行西班牙裔移植比例较高的中心,每年进行的移植手术数量更有可能较少,专门的移植床位更少,进行门诊移植的可能性较小,更有可能位于城市地区,并且拥有移植后免疫方案的可能性较小。在调整疾病严重程度后,观察到的中心因素差异与100天死亡率无关。我们的结果表明,HSCT后少数族裔报告的较差生存率可能无法轻易用中心效应来解释。